UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Form N-PX
ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED MANAGEMENT INVESTMENT COMPANY
Investment Company Act file number: | 811-22172 |
Exact name of registrant as specified in charter: | World Funds Trust |
Address of principal executive offices: | 8730 Stony Point Parkway, Suite 205 Richmond, VA 23235 |
Name and address of agent for service: | The Corporation Trust Company 1209 Orange Street Wilmington, DE 19801 |
with a copy to: Practus, LLP 11300 Tomahawk Creek Parkway, Suite 310 Leawood, KS 66211 | |
Registrant's telephone number, including area code: | 800-267-7400 |
Date of fiscal year end: | March 31st |
Date of reporting period: | July 1, 2022 to June 30, 2023 |
Item 1. Proxy Voting Record.
Perkins Discovery Fund -------------------------------------------------------------------------------------------------------------------------- AIRGAIN INC Agenda Number: 935860836 -------------------------------------------------------------------------------------------------------------------------- Security: 00938A104 Meeting Type: Annual Ticker: AIRG Meeting Date: 21-Jun-2023 ISIN: US00938A1043 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1.1 Election of Class I Director for a three-year term to Mgmt For For expire at the 2026 annual meeting: James K. Sims 1.2 Election of Class I Director for a three-year term to Mgmt For For expire at the 2026 annual meeting: Tzau-Jin Chung 2. To consider and vote upon the ratification of the Mgmt For For appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023. 3. To consider and vote upon, on an advisory basis, the Mgmt For For compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission. -------------------------------------------------------------------------------------------------------------------------- AKOUSTIS TECHNOLOGIES, INC. Agenda Number: 935714851 -------------------------------------------------------------------------------------------------------------------------- Security: 00973N102 Meeting Type: Annual Ticker: AKTS Meeting Date: 10-Nov-2022 ISIN: US00973N1028 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1. DIRECTOR Steven P. DenBaars Mgmt For For Arthur E. Geiss Mgmt For For J. Michael McGuire Mgmt For For Jeffrey K. McMahon Mgmt For For Jerry D. Neal Mgmt For For Suzanne B. Rudy Mgmt For For Jeffrey B. Shealy Mgmt For For 2. Proposal to approve, on a non-binding, advisory basis, Mgmt For For the compensation paid to our named executive officers. 3. Proposal to approve, as required by Nasdaq Marketplace Mgmt For For Rule 5635(d), the potential issuance of shares of the Company's common stock in respect of the Company's 6.0% Convertible Senior Notes due 2027 (the "2027 Notes") exceeding 19.99% of the number of shares of common stock outstanding at the time of the issuance of the 2027 Notes, including upon the conversion of the 2027 Notes, upon payment of interest thereon, and upon certain make-whole payments. 4. Proposal to approve an amendment to the Company's 2018 Mgmt For For Stock Incentive Plan to increase the number of shares reserved for issuance thereunder from 6,000,000 to 12,000,000 shares. 5. Proposal to approve an amendment to the Company's Mgmt For For Certificate of Incorporation increasing the number of authorized shares of common stock from 100,000,000 to 125,000,000 shares. 6. Proposal to approve an amendment to the Company's Mgmt For For Certificate of Incorporation to update the exculpation provision to limit the liability of certain officers of the Company as permitted by recent amendments to Delaware law. 7. Proposal to ratify the appointment of Marcum LLP as Mgmt For For the Company's independent registered public accounting firm for the fiscal year ending June 30, 2023. -------------------------------------------------------------------------------------------------------------------------- ANI PHARMACEUTICALS, INC. Agenda Number: 935822521 -------------------------------------------------------------------------------------------------------------------------- Security: 00182C103 Meeting Type: Annual Ticker: ANIP Meeting Date: 23-May-2023 ISIN: US00182C1036 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1a. Election of Director: Robert E. Brown, Jr. Mgmt For For 1b. Election of Director: Thomas Haughey Mgmt For For 1c. Election of Director: Nikhil Lalwani Mgmt For For 1d. Election of Director: David B. Nash, M.D., M.B.A. Mgmt For For 1e. Election of Director: Antonio R. Pera Mgmt For For 1f. Election of Director: Renee P. Tannenbaum, Pharm.D. Mgmt For For 1g. Election of Director: Muthusamy Shanmugam Mgmt For For 1h. Election of Director: Jeanne A. Thoma Mgmt For For 1i. Election of Director: Patrick D. Walsh Mgmt For For 2. To ratify the appointment of EisnerAmper LLP as the Mgmt For For Company's independent registered public accounting firm for the year ending December 31, 2023. 3. To approve the compensation of the Company's named Mgmt For For executive officers, on an advisory basis. 4. To approve an amendment to the Amended and Restated Mgmt For For 2022 Stock Incentive Plan. -------------------------------------------------------------------------------------------------------------------------- ASURE SOFTWARE, INC. Agenda Number: 935838550 -------------------------------------------------------------------------------------------------------------------------- Security: 04649U102 Meeting Type: Annual Ticker: ASUR Meeting Date: 15-May-2023 ISIN: US04649U1025 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1. DIRECTOR Benjamin Allen Mgmt For For W. Carl Drew Mgmt For For Daniel Gill Mgmt For For Patrick Goepel Mgmt For For Grace Lee Mgmt For For Bradford Oberwager Mgmt For For Bjorn Reynolds Mgmt For For 2. To ratify the Audit Committee's appointment of Marcum Mgmt For For LLP as our independent registered public accounting firm for the year ending December 31, 2023. 3. To approve, on a non-binding advisory basis, the Mgmt For For compensation of our named executive officers. -------------------------------------------------------------------------------------------------------------------------- ATRICURE, INC. Agenda Number: 935809268 -------------------------------------------------------------------------------------------------------------------------- Security: 04963C209 Meeting Type: Annual Ticker: ATRC Meeting Date: 25-May-2023 ISIN: US04963C2098 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1a. Election of Director: Michael H. Carrel Mgmt For For 1b. Election of Director: Regina E. Groves Mgmt For For 1c. Election of Director: B. Kristine Johnson Mgmt For For 1d. Election of Director: Karen N. Prange Mgmt For For 1e. Election of Director: Deborah H. Telman Mgmt For For 1f. Election of Director: Sven A. Wehrwein Mgmt For For 1g. Election of Director: Robert S. White Mgmt For For 1h. Election of Director: Maggie Yuen Mgmt For For 2. Proposal to ratify the appointment of Deloitte & Mgmt For For Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2023. 3. Proposal to approve the AtriCure, Inc. 2023 Stock Mgmt For For Incentive Plan. 4. Proposal to amend the AtriCure, Inc. 2018 Employee Mgmt For For Stock Purchase Plan to increase the number of shares of common stock authorized for issuance thereunder by 750,000. 5. Advisory vote on the compensation of our named Mgmt For For executive officers as disclosed in the proxy statement for the 2023 Annual Meeting. -------------------------------------------------------------------------------------------------------------------------- CANTALOUPE INC. Agenda Number: 935729686 -------------------------------------------------------------------------------------------------------------------------- Security: 138103106 Meeting Type: Annual Ticker: CTLP Meeting Date: 30-Nov-2022 ISIN: US1381031061 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1a. Election of Director: Lisa P. Baird Mgmt For For 1b. Election of Director: Douglas G. Bergeron Mgmt For For 1c. Election of Director: Ian Harris Mgmt For For 1d. Election of Director: Jacob Lamm Mgmt For For 1e. Election of Director: Michael K. Passilla Mgmt For For 1f. Election of Director: Ellen Richey Mgmt For For 1g. Election of Director: Anne M. Smalling Mgmt For For 1h. Election of Director: Ravi Venkatesan Mgmt For For 1i. Election of Director: Shannon S. Warren Mgmt For For 2. Ratification of the appointment of BDO USA, LLP as the Mgmt For For independent registered public accounting firm of the Company for fiscal year ending June 30, 2023. 3. Advisory vote on named executive officer compensation. Mgmt For For 4. Approval of an amendment to the Company's 2018 Equity Mgmt For For Incentive Plan. -------------------------------------------------------------------------------------------------------------------------- CARDIOVASCULAR SYSTEMS, INC. Agenda Number: 935713708 -------------------------------------------------------------------------------------------------------------------------- Security: 141619106 Meeting Type: Annual Ticker: CSII Meeting Date: 08-Nov-2022 ISIN: US1416191062 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1a. Election of Class II Director to hold office until the Mgmt For For 2025 Annual Meeting: Scott R. Ward 1b. Election of Class II Director to hold office until the Mgmt For For 2025 Annual Meeting: Kelvin Womack 2. To ratify the appointment of PricewaterhouseCoopers Mgmt For For LLP as the independent registered public accounting firm of the Company for its fiscal year ending June 30, 2023. 3. To approve, on an advisory basis, the compensation Mgmt For For paid to our named executive officers as disclosed in the proxy statement. -------------------------------------------------------------------------------------------------------------------------- CRYOPORT, INC. Agenda Number: 935793768 -------------------------------------------------------------------------------------------------------------------------- Security: 229050307 Meeting Type: Annual Ticker: CYRX Meeting Date: 12-May-2023 ISIN: US2290503075 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1. DIRECTOR Linda Baddour Mgmt For For Richard Berman Mgmt For For Daniel Hancock Mgmt For For Robert Hariri MD, PhD Mgmt For For Ram M. Jagannath Mgmt For For Ramkumar Mandalam, PhD Mgmt For For Jerrell W. Shelton Mgmt For For Edward Zecchini Mgmt For For 2. To ratify the appointment of Deloitte & Touche LLP as Mgmt For For the independent registered public accounting firm of the Company and its subsidiaries for the year ending December 31, 2023. 3. To approve, on an advisory basis, the compensation of Mgmt For For the named executive officers, as disclosed in this Proxy Statement. -------------------------------------------------------------------------------------------------------------------------- DIGI INTERNATIONAL INC. Agenda Number: 935749614 -------------------------------------------------------------------------------------------------------------------------- Security: 253798102 Meeting Type: Annual Ticker: DGII Meeting Date: 27-Jan-2023 ISIN: US2537981027 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1a. Election of Director: Satbir Khanuja, Ph.D. Mgmt For For 1b. Election of Director: Ronald E. Konezny Mgmt For For 2. Company proposal to approve, on a non-binding advisory Mgmt For For basis, the compensation paid to named executive officers. 3. Company proposal to ratify the appointment of Deloitte Mgmt For For & Touche LLP as independent registered public accounting firm of the company for the fiscal year ending September 30, 2023. 4. Company proposal to approve the amendment and Mgmt For For restatement of the Digi International Inc. 2021 Omnibus Incentive Plan. -------------------------------------------------------------------------------------------------------------------------- EPLUS INC. Agenda Number: 935693514 -------------------------------------------------------------------------------------------------------------------------- Security: 294268107 Meeting Type: Annual Ticker: PLUS Meeting Date: 15-Sep-2022 ISIN: US2942681071 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1.1 Election of Director: BRUCE M. BOWEN Mgmt For For 1.2 Election of Director: JOHN E. CALLIES Mgmt For For 1.3 Election of Director: C. THOMAS FAULDERS, III Mgmt For For 1.4 Election of Director: ERIC D. HOVDE Mgmt For For 1.5 Election of Director: IRA A. HUNT, III Mgmt For For 1.6 Election of Director: MARK P. MARRON Mgmt For For 1.7 Election of Director: MAUREEN F. MORRISON Mgmt For For 1.8 Election of Director: BEN XIANG Mgmt For For 2. Advisory vote (non-binding) on named executive officer Mgmt For For compensation, as disclosed in the proxy statement. 3. Proposal to ratify the selection of Deloitte & Touche Mgmt For For LLP as our independent registered public accounting firm for fiscal year 2023. 4. To approve the 2022 Employee Stock Purchase Plan. Mgmt For For 5. Advisory vote (non-binding) on the frequency of future Mgmt 1 Year For advisory votes to approve named executive officer compensation. -------------------------------------------------------------------------------------------------------------------------- EXAGEN INC Agenda Number: 935843424 -------------------------------------------------------------------------------------------------------------------------- Security: 30068X103 Meeting Type: Annual Ticker: XGN Meeting Date: 09-Jun-2023 ISIN: US30068X1037 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1.1 Election of Class I Director: Brian Birk Mgmt For For 1.2 Election of Class I Director: Tina S. Nova, Ph.D. Mgmt For For 1.3 Election of Class I Director: Ebetuel Pallares, Ph.D. Mgmt For For 2. To ratify the appointment of BDO USA, LLP as the Mgmt For For independent registered public accounting firm of Exagen Inc. for the fiscal year ending December 31, 2023. -------------------------------------------------------------------------------------------------------------------------- FLEXSHOPPER INC. Agenda Number: 935745806 -------------------------------------------------------------------------------------------------------------------------- Security: 33939J303 Meeting Type: Annual Ticker: FPAY Meeting Date: 30-Dec-2022 ISIN: US33939J3032 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1. DIRECTOR James D. Allen Mgmt For For Howard S. Dvorkin Mgmt For For Sean Hinze Mgmt For For T. Scott King Mgmt For For Thomas O. Katz Mgmt For For 2. Approval, on a non-binding basis, of the compensation Mgmt For For paid to our named executive officers. 3. Ratification of appointment of independent registered Mgmt For For public accounting firm. -------------------------------------------------------------------------------------------------------------------------- FORTRESS BIOTECH, INC. Agenda Number: 935789442 -------------------------------------------------------------------------------------------------------------------------- Security: 34960Q109 Meeting Type: Special Ticker: FBIO Meeting Date: 10-Apr-2023 ISIN: US34960Q1094 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1. Approval to Issue Rights to Acquire Contingent Mgmt For For Subsidiary Securities in Certain Subsidiaries in Order to Satisfy the Requirements of NASDAQ Listing Rule 5635(c). -------------------------------------------------------------------------------------------------------------------------- FORTRESS BIOTECH, INC. Agenda Number: 935859453 -------------------------------------------------------------------------------------------------------------------------- Security: 34960Q109 Meeting Type: Annual Ticker: FBIO Meeting Date: 21-Jun-2023 ISIN: US34960Q1094 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1. DIRECTOR Lindsay A. Rosenwald MD Mgmt For For Michael S. Weiss Mgmt For For Jimmie Harvey, Jr. M.D. Mgmt For For Malcolm Hoenlein Mgmt For For Dov Klein, CPA Mgmt For For J. Jay Lobell Mgmt For For Eric K. Rowinsky, M.D. Mgmt For For Kevin L. Lorenz, J.D. Mgmt For For Lucy Lu, M.D. Mgmt For For 2. Ratification of the appointment of KPMG LLP as Mgmt For For Fortress Biotech, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2023. 3. Amendment of the 2013 Stock Incentive Plan, as Mgmt For For amended, of Fortress Biotech, Inc. to increase the number of shares of Common Stock issuable thereunder from 16,000,000 to 23,000,000 and extend the term of the plan to December 31, 2033. 4. Amendment of the 2012 Employee Stock Purchase Plan, as Mgmt For For amended, of Fortress Biotech, Inc. to increase the number of shares of Common Stock issuable thereunder from 1,000,000 to 2,000,000. -------------------------------------------------------------------------------------------------------------------------- INUVO, INC. Agenda Number: 935857865 -------------------------------------------------------------------------------------------------------------------------- Security: 46122W204 Meeting Type: Annual Ticker: INUV Meeting Date: 15-Jun-2023 ISIN: US46122W2044 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1.1 Election of Class III Director: Charles D. Morgan Mgmt For For 1.2 Election of Class III Director: Kenneth E. Lee Mgmt For For 2. The ratification of the appointment of EisnerAmper, Mgmt For For LLP as the Company's independent registered public accounting firm. 3. An advisory vote on the frequency of future advisory Mgmt 1 Year Against votes on executive compensation. -------------------------------------------------------------------------------------------------------------------------- ISORAY, INC. Agenda Number: 935735300 -------------------------------------------------------------------------------------------------------------------------- Security: 46489V104 Meeting Type: Annual Ticker: ISR Meeting Date: 27-Jan-2023 ISIN: US46489V1044 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1. To consider and vote on a proposal to approve an Mgmt For For amendment to the Company's Certificate of Incorporation to increase the total number of authorized shares of Common Stock to 750,000,000 shares. 2. To consider and vote on a proposal, for purposes of Mgmt For For complying with applicable NYSE American rules, to approve the issuance by the Company of shares of Common Stock, par value $0.001 per share, in an amount equal to 20% or more of the amount of Company Common Stock issued and outstanding immediately prior to such issuance pursuant to the terms of the Merger Agreement, in an amount necessary to complete the Merger and the other transactions contemplated by the Merger Agreement. 3. To consider and vote on a proposal to approve an Mgmt For For amendment to the Company's Amended and Restated 2020 Equity Incentive Plan to increase the total number of shares of common stock available for awards under the Plan to 46,000,000 shares. 4. DIRECTOR Lori A. Woods Mgmt For For Philip J. Vitale, M.D. Mgmt For For Michael W. McCormick Mgmt For For Alan Hoffmann Mgmt For For 5. To ratify the appointment of Assure CPA, LLC as the Mgmt For For independent registered public accounting firm of the Company for the fiscal year ending June 30, 2023. 6. To hold an advisory vote to approve the compensation Mgmt For For of the Company's named executive officers. 7. To consider and vote on a proposal to approve the Mgmt For For adjournment of the Annual Meeting, if necessary, to ensure that any necessary supplement or amendment to the proxy statement accompanying this notice is provided to the Company's stockholders a reasonable amount of time in advance of the Annual Meeting or to solicit additional proxies if there are insufficient votes at the time of the Annual Meeting to approve adoption of the Certificate Amendment Proposal, the NYSE American Proposal, or the Equity Incentive Plan Amendment Proposal. -------------------------------------------------------------------------------------------------------------------------- JOURNEY MEDICAL CORPORATION Agenda Number: 935860521 -------------------------------------------------------------------------------------------------------------------------- Security: 48115J109 Meeting Type: Annual Ticker: DERM Meeting Date: 21-Jun-2023 ISIN: US48115J1097 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1. DIRECTOR Lindsay A. Rosenwald MD Mgmt For For Claude Maraoui Mgmt For For Neil Herskowitz Mgmt For For Jeffrey Paley, M.D. PhD Mgmt For For Justin Smith Mgmt For For Miranda Toledano Mgmt For For 2. Ratify the appointment of KPMG LLP as the Company's Mgmt For For independent registered public accounting firm for the year ending December 31, 2023. 3. Approve the Journey Medical Corporation 2023 Employee Mgmt For For Stock Purchase Plan. -------------------------------------------------------------------------------------------------------------------------- MAGNITE, INC. Agenda Number: 935849539 -------------------------------------------------------------------------------------------------------------------------- Security: 55955D100 Meeting Type: Annual Ticker: MGNI Meeting Date: 14-Jun-2023 ISIN: US55955D1000 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1a. Election of Director: Paul Caine Mgmt For For 1b. Election of Director: Doug Knopper Mgmt For For 1c. Election of Director: David Pearson Mgmt For For 2. To ratify the selection of Deloitte & Touche LLP as Mgmt For For the company's independent registered public accounting firm for the current fiscal year. 3. To approve, on an advisory basis, of the compensation Mgmt For For of the company's named executive officers. 4. To approve the Magnite, Inc. Amended and Restated 2014 Mgmt For For Equity Incentive Plan. 5. To approve the Magnite, Inc. Amended and Restated 2014 Mgmt For For Employee Stock Purchase Plan. -------------------------------------------------------------------------------------------------------------------------- MDXHEALTH SA Agenda Number: 935862741 -------------------------------------------------------------------------------------------------------------------------- Security: 58286E102 Meeting Type: Annual Ticker: MDXH Meeting Date: 25-May-2023 ISIN: US58286E1029 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management O2 Approval of the annual (non-consolidated) statutory Mgmt For financial statements Proposed resolution: The general shareholders' meeting resolves to approve the annual (nonconsolidated) statutory financial statements of the Company for the financial year ended on 31 December 2022 and to approve the allocation of the annual result as proposed by the board of directors. O4 Discharge from liability of the directors Proposed Mgmt For resolution: The general shareholders' meeting resolves to grant discharge from liability to each of the directors who was in office during the financial year ended on 31 December 2022, for the performance of its, his or her mandate during that financial year. O5 Discharge from liability of the statutory auditor Mgmt For Proposed resolution: The general shareholders' meeting resolves to grant discharge from liability to the statutory auditor which was in office during the financial year ended on 31 December 2022, for the performance of its mandate during that financial year. O6 Remuneration report Proposed resolution: The general Mgmt For shareholders' meeting resolves to approve the remuneration report included in the combined annual report of the board of directors on the consolidated and (non-consolidated) statutory financial statements of the Company for the financial year ended on 31 December 2022. O7a Re-appointment of director Proposed resolution: The Mgmt For general shareholders' meeting resolves to re-appoint Hilde Windels BV, represented by Hilde Windels as permanent representative, ...(due to space limits, see proxy material for full proposal). O7b Re-appointment of director Proposed resolution: The Mgmt Take No Action general shareholders' meeting resolves to re-appoint Regine Slagmulder BV, represented by Regine Slagmulder as permanent representative, as independent director of the Company within ...(due to space limits, see proxy material for full proposal). O7c Re-appointment of director Proposed resolution: The Mgmt For general shareholders' meeting resolves to re-appoint Eric Bednarski as director of the Company, for a term of two years, up to and ...(due to space limits, see proxy material for full proposal). O7d Re-appointment of director Proposed resolution: The Mgmt For general shareholders' meeting resolves to re-appoint Michael K. McGarrity as director of the Company, for a term of three years, ...(due to space limits, see proxy material for full proposal). O8 Re-appointment of the statutory auditor Proposed Mgmt For resolution: Taking into account the recommendation of the board of directors upon recommendation and preference of the audit committee, ...(due to space limits, see proxy material for full proposal). O9 Approval in accordance with article 7:151 of the Mgmt For Belgian ...(due to space limits, see proxy material for full proposal). E2 Proposal to issue 5,000,000 2023 Share Options: Mgmt For Proposed ...(due to space limits, see proxy material for full proposal). E4 Renewal of the authorisation to the board of directors Mgmt For to ...(due to space limits, see proxy material for full proposal). -------------------------------------------------------------------------------------------------------------------------- MDXHEALTH SA Agenda Number: 935893962 -------------------------------------------------------------------------------------------------------------------------- Security: 58286E102 Meeting Type: Special Ticker: MDXH Meeting Date: 30-Jun-2023 ISIN: US58286E1029 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 2. The general shareholders' meeting resolves to approve Mgmt For the issuance of 5,000,000 2023 Share Options, pursuant to a share option plan named the "2023 Share Option Plan", and to dis-apply, in the interest of the Company, the preferential subscription right of the existing shareholders of the Company and, insofar as required, of the holders of outstanding subscription rights (share options) or ADSs of the Company, for the benefit of Selected Participant. In view thereof, the ...(due to space limits,see proxy material for full proposal). 4. The general shareholders' meeting resolves to renew Mgmt For the authorisation to the board of directors to increase the share capital in one or several times, during a period of five (5) years as from the publication in the Annexes to the Belgian Official Gazette of this authorisation, with an aggregate amount equal to up to 100% of the amount of the share capital of the Company, and this in accordance with the terms and conditions set forth in the special report of the board of directors ...(due to space limits, see proxy material for full proposal). -------------------------------------------------------------------------------------------------------------------------- NATERA, INC. Agenda Number: 935840529 -------------------------------------------------------------------------------------------------------------------------- Security: 632307104 Meeting Type: Annual Ticker: NTRA Meeting Date: 09-Jun-2023 ISIN: US6323071042 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1. DIRECTOR Rowan Chapman Mgmt For For Herm Rosenman Mgmt For For Jonathan Sheena Mgmt For For 2. To ratify the appointment of Ernst & Young LLP as Mgmt For For Natera, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2023. 3. To approve, on an advisory (non-binding) basis, the Mgmt For For compensation of Natera, Inc.'s named executive officers as disclosed in the proxy statement. -------------------------------------------------------------------------------------------------------------------------- NEOGENOMICS, INC. Agenda Number: 935816388 -------------------------------------------------------------------------------------------------------------------------- Security: 64049M209 Meeting Type: Annual Ticker: NEO Meeting Date: 25-May-2023 ISIN: US64049M2098 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1a. Election of Director: Lynn A. Tetrault Mgmt For For 1b. Election of Director: Christopher M. Smith Mgmt For For 1c. Election of Director: Bruce K. Crowther Mgmt For For 1d. Election of Director: Dr. Alison L. Hannah Mgmt For For 1e. Election of Director: Stephen M. Kanovsky Mgmt For For 1f. Election of Director: Michael A. Kelly Mgmt For For 1g. Election of Director: David B. Perez Mgmt For For 1h. Election of Director: Rachel A. Stahler Mgmt For For 2. Approval, on an advisory basis, of the Compensation Mgmt For For Paid to the Company's Named Executive Officers. 3. Approval of the NeoGenomics, Inc. 2023 Equity Mgmt For For Incentive Plan. 4. Ratification of the Appointment of Deloitte & Touche Mgmt For For LLP as the Company's Independent Registered Public Accounting Firm. -------------------------------------------------------------------------------------------------------------------------- OPTIMIZERX CORPORATION Agenda Number: 935833548 -------------------------------------------------------------------------------------------------------------------------- Security: 68401U204 Meeting Type: Annual Ticker: OPRX Meeting Date: 07-Jun-2023 ISIN: US68401U2042 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1. DIRECTOR William J. Febbo Mgmt For For Gus D. Halas Mgmt For For Lynn O'Connor Vos Mgmt For For James Lang Mgmt For For Patrick Spangler Mgmt For For Gregory D. Wasson Mgmt For For 2. Advisory approval of the compensation of our named Mgmt For For executive officers. 3. Ratification of UHY LLP as OptimizeRx's independent Mgmt For For registered public accounting firm for the 2023 fiscal year. -------------------------------------------------------------------------------------------------------------------------- OPTION CARE HEALTH, INC. Agenda Number: 935812758 -------------------------------------------------------------------------------------------------------------------------- Security: 68404L201 Meeting Type: Annual Ticker: OPCH Meeting Date: 17-May-2023 ISIN: US68404L2016 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1. DIRECTOR John J. Arlotta Mgmt For For Elizabeth Q. Betten Mgmt For For Elizabeth D. Bierbower Mgmt For For Natasha Deckmann Mgmt For For David W. Golding Mgmt For For Harry M. J. Kraemer Jr. Mgmt For For R. Carter Pate Mgmt For For John C. Rademacher Mgmt For For Nitin Sahney Mgmt For For Timothy P. Sullivan Mgmt For For 2. To ratify the appointment of KPMG LLP as our Mgmt For For independent registered public accounting firm for the year ending December 31, 2023. 3. To approve, on a non-binding advisory basis, our Mgmt For For executive compensation. 4. To conduct an advisory vote on the frequency of a Mgmt 1 Year For stockholder vote on our executive compensation. -------------------------------------------------------------------------------------------------------------------------- PERFICIENT, INC. Agenda Number: 935830984 -------------------------------------------------------------------------------------------------------------------------- Security: 71375U101 Meeting Type: Annual Ticker: PRFT Meeting Date: 07-Jun-2023 ISIN: US71375U1016 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1a. Election of Director: Romil Bahl Mgmt For For 1b. Election of Director: Jeffrey S. Davis Mgmt For For 1c. Election of Director: Ralph C. Derrickson Mgmt For For 1d. Election of Director: Jill A. Jones Mgmt For For 1e. Election of Director: David S. Lundeen Mgmt For For 1f. Election of Director: Brian L. Matthews Mgmt For For 1g. Election of Director: Nancy C. Pechloff Mgmt For For 1h. Election of Director: Gary M. Wimberly Mgmt For For 2. Proposal to approve, on an advisory basis, the Mgmt 1 Year For frequency of the future advisory vote on executive compensation. 3. Proposal to approve, on an advisory basis, a Mgmt For For resolution relating to the 2022 compensation of the named executive officers. 4. Proposal to approve the Third Amended and Restated Mgmt For For Perficient, Inc. 2012 Long Term Incentive Plan. 5. Proposal to amend and restate the Company's Mgmt For For Certificate of Incorporation to permit the exculpation of officers. 6. Proposal to ratify KPMG LLP as Perficient, Inc.'s Mgmt For For independent registered public accounting firm for the 2023 fiscal year. -------------------------------------------------------------------------------------------------------------------------- PERION NETWORK LTD Agenda Number: 935889696 -------------------------------------------------------------------------------------------------------------------------- Security: M78673114 Meeting Type: Annual Ticker: PERI Meeting Date: 21-Jun-2023 ISIN: IL0010958192 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1a. To approve the re-election of Ms. Joy Marcus to serve Mgmt For For as a director of the Company until the third annual general meeting of shareholders of the Company following this meeting or her earlier resignation or removal, as applicable. 1b. To approve the re-election of Mr. Michael Vorhaus to Mgmt For For serve as a director of the Company until the third annual general meeting of shareholders of the Company following this meeting or his earlier resignation or removal, as applicable. 2. To approve the amendments of the Articles of Mgmt For For Association and Memorandum of Association of the Company to reflect the increase of the authorized share capital of the Company, as detailed in the Proxy Statement, dated May 17, 2023. 3. To approve amendments to the terms of employment of Mgmt For For Mr. Tal Jacobson in connection with his appointment as the Company's Chief Executive Officer, as detailed in the Proxy Statement, dated May 17, 2023. 3a. Are you a controlling shareholder (as defined in the Mgmt Against Proxy Statement) or do you have a personal interest (as defined in the Proxy Statement) in the approval of Proposal 3? (Please note: If you do not mark either 'Yes' or 'No', your shares will not be voted for this Proposal). Mark "for" = yes or "against" = no. 4. To appoint Kost Forer Gabbay & Kasierer, a member of Mgmt For For Ernst & Young Global, as the independent public auditors of the Company for the year ending on December 31, 2023, and until the next annual general meeting of shareholders, and that the board of directors of the Company, upon the recommendation of the audit committee of the Company, is authorized to determine the compensation of said independent auditors in accordance with the volume and nature of their services. -------------------------------------------------------------------------------------------------------------------------- ROCKWELL MEDICAL, INC. Agenda Number: 935843311 -------------------------------------------------------------------------------------------------------------------------- Security: 774374300 Meeting Type: Annual Ticker: RMTI Meeting Date: 23-May-2023 ISIN: US7743743004 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1a. Election of Director: Mark H. Ravich Mgmt For For 1b. Election of Director: Andrea Heslin Smiley Mgmt For For 2. Approve, on an advisory basis, the compensation of the Mgmt For For Company's named executive officers. 3. Approve, on an advisory basis, the frequency of Mgmt 1 Year For stockholder advisory votes on the compensation of the Company's named executive officers. 4. Ratify the selection of EisnerAmper LLP as the Mgmt For For Company's independent registered public accounting firm for 2023. 5. Approve an amendment and restatement of the Rockwell Mgmt For For Medical, Inc. 2018 Long Term Incentive Plan to increase the number of shares reserved for issuance thereunder by 1,600,000 shares. -------------------------------------------------------------------------------------------------------------------------- STREAMLINE HEALTH SOLUTIONS, INC. Agenda Number: 935872122 -------------------------------------------------------------------------------------------------------------------------- Security: 86323X106 Meeting Type: Annual Ticker: STRM Meeting Date: 15-Jun-2023 ISIN: US86323X1063 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1.1 Election of Director to serve until the 2024 Annual Mgmt For For Meeting: Wyche T. "Tee" Green, III 1.2 Election of Director to serve until the 2024 Annual Mgmt For For Meeting: Justin J. Ferayorni 1.3 Election of Director to serve until the 2024 Annual Mgmt For For Meeting: Kenan H. Lucas 1.4 Election of Director to serve until the 2024 Annual Mgmt For For Meeting: Jonathan R. Phillips 1.5 Election of Director to serve until the 2024 Annual Mgmt For For Meeting: Judith E. Starkey 2. To approve, on a non-binding advisory basis, the Mgmt For For compensation of our named executive officers ("say-on-pay"). 3. To ratify the appointment of the firm of FORVIS, LLP Mgmt For For to serve as our independent registered public accounting firm for fiscal year 2023. 4. To approve an amendment to the Streamline Health Mgmt For For Solutions, Inc. Third Amended and Restated 2013 Stock Incentive Plan (the "Plan"), to increase the number of shares of common stock available for issuance under the Plan. -------------------------------------------------------------------------------------------------------------------------- TACTILE SYSTEMS TECHNOLOGY, INC. Agenda Number: 935791625 -------------------------------------------------------------------------------------------------------------------------- Security: 87357P100 Meeting Type: Annual Ticker: TCMD Meeting Date: 08-May-2023 ISIN: US87357P1003 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1. DIRECTOR Valerie Asbury Mgmt For For Bill Burke Mgmt For For Sheri Dodd Mgmt For For Raymond Huggenberger Mgmt For For Daniel Reuvers Mgmt For For Brent Shafer Mgmt For For Carmen Volkart Mgmt For For 2. Ratify the appointment of Grant Thornton LLP as our Mgmt For For independent registered public accounting firm for the year ending December 31, 2023. 3. Approve, on an advisory basis, the 2022 compensation Mgmt For For of our named executive officers. -------------------------------------------------------------------------------------------------------------------------- UPHEALTH, INC. Agenda Number: 935739613 -------------------------------------------------------------------------------------------------------------------------- Security: 91532B101 Meeting Type: Annual Ticker: UPH Meeting Date: 05-Dec-2022 ISIN: US91532B1017 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1. DIRECTOR Samuel J. Meckey Mgmt For For Luis Machuca Mgmt For For Mark Guinan Mgmt For For 2. Ratification of BPM LLP as our independent registered Mgmt For For public accounting firm. 3. Amendment to Second Amended and Restated Certificate Mgmt For For of Incorporation to effect a reverse stock split of our common stock, at a specific ratio within a range of 4:1 to 10:1 to be fixed by the Board of Directors. -------------------------------------------------------------------------------------------------------------------------- VERACYTE, INC. Agenda Number: 935840581 -------------------------------------------------------------------------------------------------------------------------- Security: 92337F107 Meeting Type: Annual Ticker: VCYT Meeting Date: 08-Jun-2023 ISIN: US92337F1075 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1a. Election of Class I Director to serve until the 2026 Mgmt For For Annual Meeting of Stockholders: Robert S. Epstein 1b. Election of Class I Director to serve until the 2026 Mgmt For For Annual Meeting of Stockholders: Evan Jones 2. The ratification of the appointment of Ernst & Young Mgmt For For LLP as our independent registered public accounting firm for 2023. 3. The approval, on a non-binding advisory basis, of the Mgmt For For compensation of our named executive officers, as disclosed in our proxy statement. 4. The approval of the new Veracyte, Inc. 2023 Equity Mgmt For For Incentive Plan. 5. The adoption of an amendment to our existing restated Mgmt For For certificate of incorporation in order to declassify our Board of Directors and make other related changes. 6. The adoption of an amendment to our existing restated Mgmt For For certificate of incorporation to permit exculpation of officers by Veracyte from personal liability for certain breaches of the duty of care. -------------------------------------------------------------------------------------------------------------------------- VERICEL CORPORATION Agenda Number: 935786674 -------------------------------------------------------------------------------------------------------------------------- Security: 92346J108 Meeting Type: Annual Ticker: VCEL Meeting Date: 03-May-2023 ISIN: US92346J1088 -------------------------------------------------------------------------------------------------------------------------- Prop.# Proposal Proposal Proposal Vote For/Against Type Management 1. DIRECTOR Robert L. Zerbe Mgmt For For Alan L. Rubino Mgmt For For Heidi Hagen Mgmt For For Steven C. Gilman Mgmt For For Kevin F. McLaughlin Mgmt For For Paul K. Wotton Mgmt For For Dominick C. Colangelo Mgmt For For Lisa Wright Mgmt For For 2. To approve, on an advisory basis, the compensation of Mgmt For For Vericel Corporation's named executive officers. 3. To ratify the appointment of PricewaterhouseCoopers Mgmt For For LLP as Vericel Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2023.
SIGNATURES
Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
World Funds Trust
(Registrant)
By /s/ Karen Shupe
Name: Karen Shupe
Title: Principal Executive Officer
Date: August 29, 2023